
Metabolic Research
GLP3 30 mg
Triple-agonist research peptide studied for GIP, GLP-1 and glucagon receptor activity in metabolic models.
- Third-party HPLC & mass-spec verified
- Same-day dispatch before 2 PM ET
- Cold-packed, tamper-sealed shipping
- Batch-coded and dated at fill
Research background
Retatrutide is investigated in preclinical metabolic literature for its combined action across three incretin receptor pathways. Supplied lyophilised in a sealed, batch-coded vial with a matching third-party HPLC certificate of analysis.
Research use only. This product is supplied strictly for in-vitro laboratory research by qualified professionals. It is not a drug, food or cosmetic and must not be administered to humans or animals.
Lot analysis for this batch
- Lot
- RT30-260610
- Purity (3 vials)
- 99.68 / 99.68 / 99.62 %
- Content (3 vials)
- 35.74 / 35.65 / 35.47 mg
- Endotoxin
- 6.488 EU/vial
- Tested by
- Janoshik Analytical, Jun 2026
This analysis was commissioned by the manufacturer that supplies the material, and is published unedited.
Specifications
- Molecular formula
- C221H342N46O68
- Molar mass
- 4731.4 g/mol
- Form
- Lyophilised white powder
- Storage
- -20 °C, protect from light
- Certificate of analysis
- View batch RT30-260610
More in Metabolic Research



Tesamorelin · 10 mg
Growth hormone-releasing factor analogue studied in metabolic and body-composition research models.